These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7616742)

  • 1. Clinical development plan: N-(4-hydroxyphenyl)retinamide.
    Kelloff GJ; Crowell JA; Boone CW; Steele VE; Lubet RA; Greenwald P; Alberts DS; Covey JM; Doody LA; Knapp GG
    J Cell Biochem Suppl; 1994; 20():176-96. PubMed ID: 7616742
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical development plan: N-Acetyl-l-cysteine.
    Kelloff GJ; Crowell JA; Boone CW; Steele VE; Lubet RA; Greenwald P; Alberts DS; Covey JM; Doody LA; Knapp GG
    J Cell Biochem Suppl; 1994; 20():63-73. PubMed ID: 7616754
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical development plan: oltipraz.
    Kelloff GJ; Crowell JA; Boone CW; Steele VE; Lubet RA; Greenwald P; Alberts DS; Covey JM; Doody LA; Knapp GG
    J Cell Biochem Suppl; 1994; 20():205-18. PubMed ID: 7616744
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical development plan: vitamin E.
    Kelloff GJ; Crowell JA; Boone CW; Steele VE; Lubet RA; Greenwald P; Alberts DS; Covey JM; Doody LA; Knapp GG
    J Cell Biochem Suppl; 1994; 20():282-99. PubMed ID: 7616751
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical development plan: 2-difluoromethylornithine (DFMO).
    Kelloff GJ; Crowell JA; Boone CW; Steele VE; Lubet RA; Greenwald P; Alberts DS; Covey JM; Doody LA; Knapp GG
    J Cell Biochem Suppl; 1994; 20():147-65. PubMed ID: 7616740
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical development plan: piroxicam.
    Kelloff GJ; Crowell JA; Boone CW; Steele VE; Lubet RA; Greenwald P; Alberts DS; Covey JM; Doody LA; Knapp GG
    J Cell Biochem Suppl; 1994; 20():219-30. PubMed ID: 7616745
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical development plan: sulindac.
    Kelloff GJ; Crowell JA; Boone CW; Steele VE; Lubet RA; Greenwald P; Alberts DS; Covey JM; Doody LA; Knapp GG
    J Cell Biochem Suppl; 1994; 20():240-51. PubMed ID: 7616747
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical development plan: ibuprofen.
    Kelloff GJ; Crowell JA; Boone CW; Steele VE; Lubet RA; Greenwald P; Alberts DS; Covey JM; Doody LA; Knapp GG
    J Cell Biochem Suppl; 1994; 20():197-204. PubMed ID: 7616743
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical development plan: 18beta-glycyrrhetinic acid.
    Kelloff GJ; Crowell JA; Boone CW; Steele VE; Lubet RA; Greenwald P; Alberts DS; Covey JM; Doody LA; Knapp GG
    J Cell Biochem Suppl; 1994; 20():166-75. PubMed ID: 7616741
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical development plan: beta-carotene and other carotenoids.
    Kelloff GJ; Crowell JA; Boone CW; Steele VE; Lubet RA; Greenwald P; Alberts DS; Covey JM; Doody LA; Knapp GG
    J Cell Biochem Suppl; 1994; 20():110-140. PubMed ID: 7616738
    [No Abstract]   [Full Text] [Related]  

  • 11. Fenretinide and its relation to cancer.
    Ulukaya E; Wood EJ
    Cancer Treat Rev; 1999 Aug; 25(4):229-35. PubMed ID: 10448131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical development plan: tamoxifen.
    Kelloff GJ; Crowell JA; Boone CW; Steele VE; Lubet RA; Greenwald P; Alberts DS; Covey JM; Doody LA; Knapp GG
    J Cell Biochem Suppl; 1994; 20():252-67. PubMed ID: 7616749
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical development plan: DHEA analog 8354.
    Kelloff GJ; Crowell JA; Boone CW; Steele VE; Lubet RA; Greenwald P; Alberts DS; Covey JM; Doody LA; Knapp GG
    J Cell Biochem Suppl; 1994; 20():141-6. PubMed ID: 7616739
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical development plan: aspirin.
    Kelloff GJ; Crowell JA; Boone CW; Steele VE; Lubet RA; Greenwald P; Alberts DS; Covey JM; Doody LA; Knapp GG
    J Cell Biochem Suppl; 1994; 20():74-85. PubMed ID: 7616755
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical development plan: calcium.
    Kelloff GJ; Crowell JA; Boone CW; Steele VE; Lubet RA; Greenwald P; Alberts DS; Covey JM; Doody LA; Knapp GG
    J Cell Biochem Suppl; 1994; 20():86-109. PubMed ID: 7616756
    [No Abstract]   [Full Text] [Related]  

  • 16. Cancer risk factors for selecting cohorts for large-scale chemoprevention trials.
    Greenwald P
    J Cell Biochem Suppl; 1996; 25():29-36. PubMed ID: 9027595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapeutic evaluation of N-(4-hydroxyphenyl) retinamide-O-glucuronide in the rat mammary tumor model.
    Abou-Issa H; Curley RW; Panigot MJ; Tanagho SN; Sidhu BS; Alshafie GA
    Anticancer Res; 1997; 17(5A):3335-9. PubMed ID: 9413168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical development plan: Proscar.
    Kelloff GJ; Crowell JA; Boone CW; Steele VE; Lubet RA; Greenwald P; Alberts DS; Covey JM; Doody LA; Knapp GG
    J Cell Biochem Suppl; 1994; 20():231-9. PubMed ID: 7616746
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical development plan: vitamin D3 and analogs.
    Kelloff GJ; Crowell JA; Boone CW; Steele VE; Lubet RA; Greenwald P; Alberts DS; Covey JM; Doody LA; Knapp GG
    J Cell Biochem Suppl; 1994; 20():268-81. PubMed ID: 7616750
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical development plan: curcumin.
    J Cell Biochem Suppl; 1996; 26():72-85. PubMed ID: 9154169
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.